학술논문
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Document Type
Article
Author
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; De Porre, Peter; Yu, Margaret K; Park, Youn C; Li, Jinhui; Kheoh, Thian; Naini, Vahid; Molina, Arturo; Rathkopf, Dana E
Source
In Lancet Oncology February 2015 16(2):152-160
Subject
Language
ISSN
1470-2045